Search
for
Sort by
Research 871–900 of 1000+
- Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
- Recovery of nail dystrophy potential new therapeutic indication of tofacitinib
- Switching JAK inhibitors: evaluating baricitinib’s effectiveness in alopecia areata after tofacitinib failure
- COMPARISON OF EFFICACY OF BARICITINIB VERSUS METHOTREXATE THERAPY IN THE TREATMENT OF SEVERE ALOPECIA AREATA
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Real-World Effectiveness of JAK Inhibitors for Alopecia Totalis and Alopecia Universalis: A Single-Center Experience
- Etrasimod for alopecia areata: The scenario for a less extensive and moderate form
- Letter to the Editor: A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Healthcare System
- JAK inhibitors in dermatology: The promise of a new drug class
- Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata
- Molecular docking studies and ADME-Tox prediction of phytocompounds from Merremia peltata as a potential anti-alopecia treatment
- Interleukin-15 and Tumor Necrosis Factor-α in Iraqi Patients with Alopecia Areata
- Genes and Immune Response in Alopecia Areata: Review of the Alopecia Areata Research Summit First Day Proceedings
- Pathophysiology of Alopecia Areata in the Pediatric Patient
- Quality of Life and Mood Status Disturbances in Cohabitants of Patients with Alopecia Areata: A Cross-Sectional Study in a Spanish Population
- Efficacy and Potential Mechanisms of Naringin in Atopic Dermatitis
- Selective Delivery of Tofacitinib Citrate to Hair Follicles Using Lipid-Coated Calcium Carbonate Nanocarrier Controls Chemotherapy-Induced Alopecia Areata
- ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata
- Stem cell-based therapies for alopecia areata: a narrative review
- Optimization of photobiomodulation therapy for spinal cord injury: A review
- A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- Dermatological Indications: Alopecia Areata
- Autoinmune Alopecia/Alopecia Areata
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Efficacy of mesalazine in children with moderate to severe alopecia areata: case series of 18 patients
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- The Roles of Exosomes in Regulating Hair Follicle Growth
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata